{"id":"https://openalex.org/W4382394436","doi":"https://doi.org/10.1158/1078-0432.c.6717737.v1","title":"Data from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer","display_name":"Data from A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer","publication_year":2023,"publication_date":"2023-06-28","ids":{"openalex":"https://openalex.org/W4382394436","doi":"https://doi.org/10.1158/1078-0432.c.6717737.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6717737.v1","doi":"https://doi.org/10.1158/1078-0432.c.6717737.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6717737.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.6717737.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069398684","display_name":"Jamunarani Veeraraghavan","orcid":"https://orcid.org/0000-0002-9524-9487","observed_orcids":["https://orcid.org/0000-0002-9524-9487"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jamunarani Veeraraghavan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9524-9487","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023898240","display_name":"Carolina Guti\u00e9rrez","orcid":"https://orcid.org/0000-0002-2941-3461","observed_orcids":["https://orcid.org/0000-0002-2941-3461"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carolina Gutierrez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-2941-3461","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026237890","display_name":"Carmine De Angelis","orcid":"https://orcid.org/0000-0003-1158-4630","observed_orcids":["https://orcid.org/0000-0003-1158-4630"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carmine De Angelis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1158-4630","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060286977","display_name":"Robert Davis","orcid":"https://orcid.org/0009-0004-2031-9729","observed_orcids":["https://orcid.org/0009-0004-2031-9729"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Davis","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-2031-9729","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100453671","display_name":"Tao Wang","orcid":"https://orcid.org/0000-0003-1957-7160","observed_orcids":["https://orcid.org/0000-0003-1957-7160","https://orcid.org/0009-0001-5011-0043"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tao Wang","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1957-7160","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043895722","display_name":"Tom\u00e1s Pascual","orcid":"https://orcid.org/0000-0001-8431-3183","observed_orcids":["https://orcid.org/0000-0001-8431-3183"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomas Pascual","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8431-3183","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014140313","display_name":"Pier Selenica","orcid":"https://orcid.org/0000-0003-0086-0513","observed_orcids":["https://orcid.org/0000-0003-0086-0513"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pier Selenica","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0086-0513","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037599751","display_name":"Katherine Sanchez","orcid":"https://orcid.org/0000-0001-8327-6464","observed_orcids":["https://orcid.org/0000-0001-8327-6464"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katherine Sanchez","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8327-6464","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067876249","display_name":"Hiroaki Nitta","orcid":"https://orcid.org/0000-0001-8595-3182","observed_orcids":["https://orcid.org/0000-0001-8595-3182"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroaki Nitta","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8595-3182","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008261350","display_name":"Monesh J. Kapadia","orcid":"https://orcid.org/0000-0002-9081-8468","observed_orcids":["https://orcid.org/0000-0002-9081-8468"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Monesh Kapadia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9081-8468","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082726917","display_name":"Anne C. Pavlick","orcid":"https://orcid.org/0000-0002-9638-9318","observed_orcids":["https://orcid.org/0000-0002-9638-9318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne C. Pavlick","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9638-9318","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059201728","display_name":"Patricia Galv\u00e1n","orcid":"https://orcid.org/0000-0002-8153-0307","observed_orcids":["https://orcid.org/0000-0002-8153-0307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Patricia Galvan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8153-0307","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070245444","display_name":"Brent Neil Rexer","orcid":"https://orcid.org/0000-0002-0341-7392","observed_orcids":["https://orcid.org/0000-0002-0341-7392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brent Rexer","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0341-7392","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046549002","display_name":"Andres Forero","orcid":"https://orcid.org/0000-0001-8904-2626","observed_orcids":["https://orcid.org/0000-0001-8904-2626"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andres Forero-Torres","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1360-1695","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005007467","display_name":"Rita Nanda","orcid":"https://orcid.org/0000-0001-5248-0876","observed_orcids":["https://orcid.org/0000-0001-5248-0876"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rita Nanda","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5248-0876","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053390874","display_name":"Anna Maria Storniolo","orcid":"https://orcid.org/0000-0002-8701-7889","observed_orcids":["https://orcid.org/0000-0002-8701-7889"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna M. Storniolo","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8701-7889","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032785430","display_name":"Ian E. Krop","orcid":"https://orcid.org/0000-0002-6380-5944","observed_orcids":["https://orcid.org/0000-0002-6380-5944"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ian E. Krop","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6380-5944","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008665323","display_name":"Matthew Philip Goetz","orcid":"https://orcid.org/0000-0002-4383-270X","observed_orcids":["https://orcid.org/0000-0002-4383-270X","https://orcid.org/0000-0003-3588-024X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew P. Goetz","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4383-270X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007261291","display_name":"Julie R. Nangia","orcid":"https://orcid.org/0000-0002-8326-2254","observed_orcids":["https://orcid.org/0000-0002-8326-2254"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie R. Nangia","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8326-2254","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026024346","display_name":"Antonio C. Wolff","orcid":"https://orcid.org/0000-0003-3734-1063","observed_orcids":["https://orcid.org/0000-0003-3734-1063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Antonio C. Wolff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3734-1063","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040506127","display_name":"Britta Weigelt","orcid":"https://orcid.org/0000-0001-9927-1270","observed_orcids":["https://orcid.org/0000-0001-9927-1270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Britta Weigelt","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9927-1270","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077235697","display_name":"Jorge Sergio Reis-Filho","orcid":"https://orcid.org/0000-0003-2969-3173","observed_orcids":["https://orcid.org/0000-0003-2969-3173"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge S. Reis-Filho","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2969-3173","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073398031","display_name":"Susan Galloway Hilsenbeck","orcid":"https://orcid.org/0000-0002-7962-673X","observed_orcids":["https://orcid.org/0000-0002-7962-673X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susan G. Hilsenbeck","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7962-673X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089513581","display_name":"Aleix Prat","orcid":"https://orcid.org/0000-0003-2377-540X","observed_orcids":["https://orcid.org/0000-0003-2377-540X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Aleix Prat","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2377-540X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037774999","display_name":"C. Kent Osborne","orcid":"https://orcid.org/0000-0002-0044-618X","observed_orcids":["https://orcid.org/0000-0002-0044-618X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Kent Osborne","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0044-618X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030115311","display_name":"Rachel Schiff","orcid":"https://orcid.org/0000-0003-1696-5213","observed_orcids":["https://orcid.org/0000-0003-1696-5213"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachel Schiff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1696-5213","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072850149","display_name":"Mothaffar Fahed Rimawi","orcid":"https://orcid.org/0000-0002-4284-5656","observed_orcids":["https://orcid.org/0000-0002-4284-5656"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mothaffar F. Rimawi","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4284-5656","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9761000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.020800000056624413,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/neoadjuvant-therapy","display_name":"neoadjuvant therapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/lapatinib","display_name":"lapatinib","score":0.949999988079071},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":1.0},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.8700000047683716},{"id":"https://openalex.org/keywords/molecular-classifier","display_name":"molecular classifier","score":0.6840000152587891},{"id":"https://openalex.org/keywords/pik3ca-mutation","display_name":"PIK3CA mutation","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pam50","display_name":"PAM50","score":0.7730000019073486},{"id":"https://openalex.org/keywords/her2-targeted-therapy","display_name":"HER2-targeted therapy","score":0.574999988079071},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.625}],"concepts":[{"id":"https://openalex.org/C2777329042","wikidata":"https://www.wikidata.org/wiki/Q420323","display_name":"Lapatinib","level":5,"score":0.7932594418525696},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7464966773986816},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.7279747128486633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.595241904258728},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5154958367347717},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48876285552978516},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.447083055973053},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.30023443698883057}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6717737.v1","doi":"https://doi.org/10.1158/1078-0432.c.6717737.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6717737.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6717737.v1","doi":"https://doi.org/10.1158/1078-0432.c.6717737.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.6717737.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.7900000214576721,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2166148619","https://openalex.org/W1967506091","https://openalex.org/W2326908302","https://openalex.org/W2989981638","https://openalex.org/W2167587342","https://openalex.org/W2262572336","https://openalex.org/W1964065629","https://openalex.org/W2530207093","https://openalex.org/W3098385676","https://openalex.org/W67104293"],"abstract_inverted_index":{"AbstractBackground:":[0],"Clinical":[1],"trials":[2],"reported":[3],"25%":[4],"to":[5,262],"30%":[6],"pathologic":[7],"complete":[8],"response":[9,110],"(pCR)":[10],"rates":[11],"in":[12,113,122,227,273],"HER2+":[13,47],"patients":[14,32,230,246],"with":[15,19,33,61,209,267],"breast":[16,48,128],"cancer":[17,49,129],"treated":[18],"anti-HER2":[20,263,271],"therapies":[21],"without":[22],"chemotherapy.":[23],"We":[24],"hypothesize":[25],"that":[26],"a":[27,40,116],"multiparameter":[28,242],"classifier":[29,108,174,243],"can":[30],"identify":[31],"HER2-\u201caddicted\u201d":[34],"tumors":[35],"who":[36,231,247,256],"may":[37,232,248],"benefit":[38,249],"from":[39,51,250,254],"chemotherapy-sparing":[41],"strategy.":[42],"Patients":[43],"and":[44,54,63,82,88,102,107,134,151,159,166,187,189,193,197,216,259],"Methods:":[45],"Baseline":[46],"specimens":[50,130],"the":[52,68,162,173],"TBCRC023":[53,114],"PAMELA":[55,207],"trials,":[56],"which":[57,138],"included":[58],"neoadjuvant":[59],"treatment":[60,238],"lapatinib":[62],"trastuzumab,":[64],"were":[65,92,111],"used.":[66],"In":[67,125],"case":[69],"of":[70,109,137,146],"estrogen":[71],"receptor\u2013positive":[72],"(ER+)":[73],"tumors,":[74],"endocrine":[75],"therapy":[76,252,264,272],"was":[77,175],"also":[78],"administered.":[79],"HER2":[80,147,178],"protein":[81,97],"gene":[83,96],"amplification":[84],"(ratio),":[85],"HER2-enriched":[86],"(HER2-E),":[87],"PIK3CA":[89,167],"mutation":[90],"status":[91],"assessed":[93],"by":[94],"dual":[95,270],"assay":[98],"(GPA),":[99],"research-based":[100],"PAM50,":[101,133],"targeted":[103],"DNA-sequencing.":[104],"GPA":[105],"cutoffs":[106,145],"constructed":[112],"using":[115,205],"decision":[117],"tree":[118],"algorithm,":[119],"then":[120],"validated":[121],"PAMELA.":[123],"Results:":[124],"TBCRC023,":[126],"72":[127],"had":[131,140],"GPA,":[132],"sequencing":[135,160],"data,":[136,161],"15":[139],"pCR.":[141],"Recursive":[142],"partitioning":[143],"identified":[144],"ratio":[148,179],"\u2265":[149,155,180,185],"4.6":[150],"%3+":[152,182],"IHC":[153,183],"staining":[154,184],"97.5%.":[156],"With":[157],"PAM50":[158],"model":[163],"added":[164],"HER2-E":[165],"wild-type":[168],"(WT).":[169],"For":[170],"clinical":[171],"implementation,":[172],"locked":[176],"as":[177],"4.5,":[181],"90%,":[186],"PIK3CA-WT":[188],"HER2-E,":[190],"yielding":[191],"55%":[192],"94%":[194],"positive":[195],"(PPV)":[196],"negative":[198],"(NPV)":[199],"predictive":[200],"values,":[201],"respectively.":[202],"Independent":[203],"validation":[204],"44":[206],"cases":[208],"all":[210],"three":[211],"biomarkers":[212],"yielded":[213],"47%":[214],"PPV":[215],"82%":[217],"NPV.":[218],"Importantly,":[219],"our":[220],"classifier's":[221],"high":[222],"NPV":[223],"signifies":[224],"its":[225],"strength":[226],"accurately":[228],"identifying":[229],"not":[233],"be":[234],"good":[235],"candidates":[236],"for":[237],"deescalation.":[239],"Conclusions:":[240],"Our":[241],"differentially":[244],"identifies":[245],"HER2-targeted":[251],"alone":[253,265],"those":[255],"need":[257],"chemotherapy":[258,268],"predicts":[260],"pCR":[261],"comparable":[266],"plus":[269],"unselected":[274],"patients.":[275]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}